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ABSTRACT
During the six months covered by this report (November 1973 -
30 April 1974), the Laboratory of Aerospace Biology conducted an ex-
periment to determine the effects of air velocity on metabolic performance.
The significance of this research relates to the use of high forced airflow
in a closed environment as a mechanism to control the concentration of
volatile animal wastes. Air velocities between 100 and 200 ft/min are
without significant effects on the metabolism of rats. At velocities of
200 ft/min and above, oxygen consumption and CO 2 production as well
as food consumption increase. In most instances, the changes are on
the order of 5-10%. At the same time, the RQ for the animals increased
slightly and generally correlated well with the oxygen consumption and
CO 2 production.
The Laboratory of Aerospace Biology also conducted its concluding
experiments on the nature of inert gas narcosis during this six month
period. Utilizing the electron transport particle prepared from rat
liver mitochondria, the NADH:0 2 oxidoreductase activity was inhibited
in vitro by argon gases but only at relatively high pressures (120 ATM but
not at 50 or 75 ATM). Utilizing the luciferin-luciferase enzyme system
prepared from firefly tails, both argon and nitrous oxide showed marked
inhibition. Luciferase was inhibited by argon at pressures of 50 and
100 ATM and the ED 5 0 for N 2 0 was 23 ATM. In these in vitro
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experiments, both halothane and methoxyflurane were observed 
to be
rather potent inhibitors of the NADH:0 2 oxidoreductase system. These
experiments suggest that the mechanism of inert gas narcosis 
is not
mandatorily related to a membrane surface phenomenon.
The report also includes new data and an up-date of a technique
developed in this laboratory for a rapid quantitative measure of compara-
tive metabolic activity which has been prepared in manuscript form for
submission to the editors of Comparative Biochemistry and Physiology.
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EFFECTS OF CHRONIC EXPOSURE TO AIRFLOW OF MODERATE
VELOCITIES ON METABOLISM
Introduction:
The control of volatile animal wastes under the weightless environ-
ment of space is a problem of no small magnitude. Although several
methods have been devised to control and contain volatile waste material,
the one which currently shows some promise involves the removal of this
material by forced airflow; a similar method was used to control volatile
human waste on Skylab. Even though the velocities of airflow under consider-
ation are not great, they may be sufficient to pose a chronic environmental
stress on the animals subjected.
At the request of Dr. Emily Holton, NASA-Ames Research Center,
an investigation was conducted on the effects on the metabolism of white
rats chronically exposed to airflow at several velocities under 1 ATA air
at an environmental temperature within the animals' thermal neutral
range. The results of this investigation indicate that air velocities in
excess of 200 feet/minute do impose a stress on the animals. Although
the changes observed are fairly small, they may prove to be significant.
Method and Materials:
To conduct this study a metabolic chamber was fitted with tubular
cage to house the animals, fan and other equipment. The cage was
constructed of 26 gauge stainless steel and measured 31" long by 12"
in diameter. The bottom of this tube was sealed except for a rectangular
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hole for the fan discharge and two 2.5" x 8" slots cut in the tube wall
for regulating airflow. The fan, a Dayton model 4C264 centrifugal blower
with a no-load rating of 465 ft 3 /min at sea level, was mounted directly
over the discharge hole. The floor of the animal compartment was set
on "L" brackets 10" below the upper end of the tube and was constructed
of heavy-gauge expanded stainless steel having an open cross section of
0.8 ft 2 . A circular drop tray was similarly mounted on brackets midway
between the cage floor and the fan. Its diameter was 1" less than the
diameter of the tube permitting a relatively unrestricted flow of air from
the animal compartment to the fan. Additionally, a 3.5" in diameter
hole was cut in the center of the tray to insure a uniform cross section of
airflow. This hole was surrounded by 1. 5 ' high collar and covered with
a 4" in diameter cone to retard the deposition of animal waste in the fan
compartment. The upper end of the tube was covered with an open-cell
material (Hexcel) 1. 5" thick to reduce air turbulance within the animal
compartment.
Mounted in the animal compartment were a food hopper, water
cup, 4-watt fluorescent lamp, thermoswitch and thermocouple. The
food hopper was positioned out of the air stream along the wall of the
animal compartment and held about 425 gm of Purina Rat Chow. The
water cup was mounted next to the food hopper and had a 75 ml capacity;
it was automatically filled every 2 hours. The fluorescent lamp was
secured above the food hopper and water cup at the edge of the air stream
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and was controlled by a time switch providing a 12:12 LD cycle. The
thermoswitch and thermocouple were mounted together in a wire mesh
enclosed pod located in the air stream 8" above the animal compartment
floor on the central axis of the tube.
When the chamber was sealed, fresh air was continuously intro-
duced at the top of the chamber at the rate of 7.4 1/min, pulled through
the animal compartment by the blower, and exhausted at the bottom of
the chamber. The average 02 and CO 2 concentrations within the chamber
were about 20% and 0.6%, respectively.
Oxygen consumption and CO 2 production were derived from
measurements made at 4 hour intervals 5 times daily starting at 0800 hours.
Oxygen and CO 2 in the effluent line of the chamber were quantified by
gas chromatography using a Varian A350B gas chromatograph equipped
with a dual thermal conductivity detector. CO 2 was resolved on a 0.25"
x 24" silical gel column operated at 120 0 C while oxygen and nitrogen were
resolved on a 0.25" x 120" mole sieve 5 A column operated at room temper-
ature. Helium was used as the carrier gas. Gas samples were injected
onto the columns at a pressure of 1 ATA with a sample valve equipped with
a 0.5 ml sample loop. The gas standard containing 1. 56% CO 2 , 20.7% 02
and 77.7% nitrogen was applied to the columns at the same pressure and
volume. The CO 2 and 02 concentrations were calculated by linear extrapo-
lation of sample peak areas based on areas of the gas standard peaks. Peak
areas were calculated by multiplying peak width at half height by peak height.
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The overall error of this method averaged + 5%0. Sample data were con-
verted to 1/day based on the gas flow through the chamber over a 24-hour
period beginning at midnight.
Air velocity was periodically monitored with a Thermo-Systems model
4100 ionization-type airflow meter. The air stream was measured at 5
equidistant points midway between the center and periphery of the animal
compartment floor and averaged. The average value was corrected to
1 ATA and 28 0 C.
Four male rats (Caworth Farms) weighing 300 + 20 gms were
placed in the chamber for 1 week at 1 ATA and an airflow of 16 ft/min
+ 20% for acclimatization and to check the system's performance. The
experiment was initiated at the beginning of the second week without
changing airflow or pressure. One week control and experimental periods
were alternated. The chamber temperature was maintained at 28.5
0 C +
0. 50C throughout. The experimental air velocities were 116 + 15%,
216 + 10%, and 329 ft/min + 10%. The latter value represents the highest
airflow obtainable in this particular system.
On the 2nd, 4th and 7th day of each control and experimental period,
all the rats were injected (IP) with 2 - 1 4 C-acetate (adjusted to pH 7.4 with
80 mM phosphate buffer) at a rate of 50pCi/kg. During a 2-hour period
beginning immediately after injection, total CO 2 was trapped at 10-minute
intervals in liquid scintillation counting vials containing 0. 1% hyamine
hydroxide and 0. 01% phenolpthalein dissolved in a dioxane-based liquid
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scintillation cocktail. The samples were subsequently counted in a L/S
spectrometer.
Prior to injection, the animals were weighed and food replaced.
The food remaining in the hopper was dried at room temperature for 48
hours and weighed. The difference between the initial and final weights
was taken as the measure of food consumption. Water consumption was not
quantified.
All data are expressed as per unit of metabolic mass rather than body
mass. The use of metabolic mass corrects the data, in part, for the
change in body mass and consequently, metabolic rate, of the animals
during the course of the experiment. Metabolic mass was calculated by
converting individual animal weights ( in kilograms ) to their 0.75 power
and summing to obtain total metabolic mass.
Results:
Under the conditions of this experiment both CO 2 production and 02
consumption rates increased with an increase in airflow. The greatest
change in C02 production (8%) was at an air velocity of 329 ft/min. The
greatest change in 02 consumption was a 12% increase above the control
level. This, however, occurred at 216 ft/min and the increase in 02
consumption at 329 ft/min was only 4%. The correlation coefficients
between change in CO 2 production or 02 consumption and air velocity are
0.867 (P<0.01) and 0.558 (P>0.05), respectively. Curves for CO 2
production, 02 consumption, and RQ plotted against treatment are presented
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in Figure 1.
The rate of food consumption (Figure 2) changes in a manner
similar to the respiratory data. The greatest change occurred at 329
ft/min, and was 7% above the control level. Lesser changes were ob-
served at 116 and 216 ft/min. The correlation between change in rate
of food consumption and airflow was 0. 820 (P<0. 05).
The rate of change of metabolic mass (essentially weight) also
varies in a manner which correlates significantly with air velocity
(r=0.751, P<0.05). The greatest change in rate of mass gain, aside from
the initial control period, was an increase of 63% at 329 ft/min. A 13%
increase in gain rate was observed at 216 ft/min. The change in gain
rate at 116 ft/min, although large is negative and appears to be related
to events occurring before and during the initial control period. These
data are shown in Figure 2.
The production of 1 4 C0 2 from 2- 1 4 C-acetate (Figure 3) declines from
the initial control period to the period of highest air velocity, and the
rate at which 14CO 2 production decreases over this period is influenced
by the air velocity, the rate being lower at increased air velocities.
The largest change, 20%, occurred at 329 ft/min. The correlation coef-
ficient of air velocity versus percent change in 14C02 production is
0.793 (P<0.05).
The percent change of the metabolic parameters is presented in
Table 1. The values represent the change in a given parameter from the
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Figure 1. Mean Rate of Oxygen Consumption, Carbon Dioxide Production, and RQ
Plotted Versus Treatment Period. Oxygen consumption and CO 2 values on
ordinate are expressed in liters per kilogram of metabolic mass per day.
Vertical bars are the standard error. Control air velocity is 16 ft/min
+ 20%. Each period is approximately of 7 days duration.
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Figure 2. Mean Rate of Food Consumption and Metabolic Mass Gain Plotted Versus Treatment
Period. Food consumption is expressed as grams per kilo rm of metabolic
mass per day while the units for weight gain are kilograms 14 per day.
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Figure 3. Quantity of 14CO 2 Produced by Rats Following Injection (IP) of 2-14 C-acetate 
Expressed
as the Mean of the Percent uCi Recovered of the Total Amount of uCi Injected per
Kilogram of Metabolic Mass. Vertical bars are the standard error.
TABLE I. Percent Change in Metabolic Parameters Relative to Air Velocity.
(+= increase from previous level, and - = decrease from previous level.
r = correlation coefficient between metabolic parameter and airflow.)
Rate of1402 Consumption CO 2 Production CO 2 Production Food Consumption Wt. Gain
Airflow A % % % A % A%
Control* 0 0 0 0 0
116 ft/min +0.7 +1.5 -7.0 +3.5 -54.0
Control -5.0 -6.0 -11.0 -7.0 -27.0
216 ft/min +12.0 +6.0 -4.0 +0.8 +13.0
Control -12.0 -11.0 -7.0 -5.0 -13.0
329 ft/min +4.0 +8.0 +20.0 +7.0 +63.0
Control +0.9 -6.0 -8.0 -8.0 -54.0
r 0.558 0.867 0.793 0.820 0.751
(significance
level) (P > 0. 05) (P < 0. 01) (P < 0. 05) (P < 0. 05) (P < 0. 05)
* control air velocity = 16 ft/min + 20%.
previous level with the initial control period arbitrarily set at 0%
change. The correlation coefficients for these data versus air velocity
are also shown in this table.
Discussion:
The data indicate that chronic exposure to airflow of moderate
velocities was stressful. This conclusion derives from changes observed
in the metabolic rate and in the apparent oxidized substrate. These effects
are most likely attributable to a change in the rate of heat loss, since the
variation in several of the metabolic parameters is nearly proportional
to the variation in air velocity.
At 116 ft/min both oxygen consumption and CO 2 production in-
creased slightly and were accompanied by a fairly large increase in the
rate of food consumption. RQ, however, shifted upward slightly from 0. 83
to 0.84 while the rate of metabolic mass gain dropped rather precipitously.
The turnover of labeled acetate was similarly enhanced, but was quite small.
The data from this period are complicated by difficulties encountered with
the water delivery and temperature control systems during the previous
two weeks and by the fact that the rats were quite young and in the rapid
growth phase. Thus it appears that the principal metabolic activity was
directed toward synthesis of fat, structural protein and other materials,
the increase in heat loss being offset by a slightly higher rate of carbohy-
drate oxidation. During the subsequent control period all parameters
returned to pre-exposure levels or lower.
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On exposure to an air velocity of 216 ft/min, again most parameters
were elevated; however, RQ dropped from 0.83 to 0.79. If the difference
is significant, it could indicate a greater dependence on the oxidation
of lipid or possible proteinaceous substrates. There appeared to be,
however, a net synthesis of material since the rate of mass gain increases.
It may be more appropriate to refer to this as an increase in the rate of gain of
apparent metabolic mass, since it is not possible to estimate the hydration
state of the rats during this time. Much of the mass increase could simply
be a change in body water. On the return to low air velocity the apparent
substrate preference was unchanged and the other parameters returned to
levels below those of the pre-exposure period.
Exposure to the highest air velocity, 329 ft/min, elevated the
metabolic rate rather dramatically. It is most apparent that the rats
were stressed. RQ coupled with other parameters indicates an apparent
net synthesis of fat. Although at first this seems incompatible with high
rate of acetate oxidation to CO 2 , one must assume that the flux of acetate
through the oxidative pathway is increased in proportion to rate of incorpora-
tion into fatty acids. Indeed, on return to control conditions, RQ dropped
from 0.82 to 0.76 while 02 consumption increases slightly. 14 CO 2 production
from acetate in this instance did not decrease to the anticipated control
level. Thus, it appears that a considerable quantity of lipid was synthesized
during the period of high air velocity perhaps to serve as insulation to
offset increased heat loss. On return to control air velocity this lipid
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material would be an impediment to body temperature regulation and
subsequently may be preferentially oxidized.
Heat production, calculated from 02 consumption and RQ data
according to Kleiber (1), during the periods of high air velocity increased
from an average of 152 kcal/kg3/4/day to an average of 160 kcal/kg3/4/day,
a difference of 5%. The potential rate of heat loss, however, was on the
average 4-fold greater (3.4 to 12.4 kcal/dm 2 /day) at the elevated air velocities.
The discrepancy between heat production and heat loss is due to the
efficiency of the animals' body insulation, e.g. fur and subcutaneous fat.
In summary, it would seem that air velocities up to 200 ft/min
are without significant effect on the metabolism of rats. An affect becomes
apparent at velocities in the neighborhood of 200 ft/min and is considerable
at higher velocities. In most instances the changes observed in the
metabolic parameters were quite small being on the order of 5-10% and
were accompanied by large standard errors. Consequently, they are
statistically nonsignificant. Additional replication would attenuate the
error to a level of acceptable statistical significance.
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IN VITRO EXPERIMENTS ON THE NATURE OF INERT GAS NARCOSIS
Introduction:
This report details work done during the past few months on the
effect of both clinical inhalation anesthetics and argon on foreward and
reverse electron transport by submitochondrial particles. Additionally,
data are presented on the affect of nitrous oxide and argon on firefly
luciferase activity. Background literature has been discussed previously
in the October 1972 and October 1973 Status Reports.
Methods and Materials:
The luciferin-luciferase system was prepared from desiccated
firefly tails (Sigma). 50 mg of the tails were suspended in 4 ml of 0. 1 M
sodium arsenate buffer (pH 7. 4) at OoC and sonicated in a 1 M CaC12 ice
bath for two minutes with a Bronson model W-350 sonifier at an indicated
input to the microtip of 75 watts. The sonicate was transferred to a 9 ml
polycarbonate centrifuge tube and two 1 ml washings of the sonication
vessel were added. It was then centrifuged at 100,000 x g (ave RCF) for
30 minutes at 20C in a Beckman Type 40 Rotor. The resulting supernatant
was brought up to about 6 ml and crystalline MgC12 added to a final concen-
tration of 40 mM. This preparation was then stored at 0 0 C for no longer
than 4 hours before use.
Luciferase activity was assayed by transferring 0.5 ml of the
supernatant to the high pressure cell, the head space in the cell was
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purged with medical grade oxygen, the cell sealed and then pressurized with
either helium, argon, or nitrous oxide. Gas was either obtained directly
from the cylinder or from a hydraulic pressure accumulator depending on
the pressure required. Following a ten minute preincubation period, the
reaction was initiated with 10 Il of 10.3 mM ATP. The temperature of
the cell was maintained at 22 + 0.2 0 C. Luciferin light emission was
monitored with a Beckman DK-2A spectrophotometer, the photomultiplier
preamplifier of which was chopper stabilized. The output of the spectro-
photometer was recorded on a strip-chart recorder and adjusted so
that the initial controls would produce between a 90 and 95% full scale
response of the recorder. Light intensity was arbitrarily taken from a
point on the intensity decay curve 6-12 seconds after the initiation of the
reaction.
The assay of NADH:O 2 oxidoreductase activity was performed as
described in the October 1973 Status Report. The procedure for assaying
succinate:NAD oxidoreductase activity was inadvertantly omitted from
the previous report and is now described. An aliquot containing up to
300 ug of submitochondrial particle (ETP p) protein is added to a volume
of assay medium containing 40 mM triethanolamine buffer (pH 7.8), 6 mM
MgC12 , 1.5 mM KCN, and 0.3 M mannitol. Succinate and NAD are then
added to a final concentration of 5 mM and 1 mM, respectively. The
reaction is initiated by addition of ATP to a final concentration of 3 mM.
The change in absorbance at 340 nm and 25 0 C is followed on a strip-chart
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recorder and the rate of change is calculated from the linear portion of the
curve.
The studies of these enzyme activities as affected by some of the
clinical inhalation anesthetics was repeated using a procedure somewhat
different than outlined in October 1973 Status Report. Rather than adding
the anesthetic directly to the assay medium, the assay medium was
equilibrated with the anesthetic in the gas phase. Air was bubbled through
a small vaporizer, maintained in a constant temperature bath and mixed
on the effluent side with additional air to produce the desired concentration
of anesthetic. The mixture was passed over a 25 ml volume of assay
medium in a 50 ml filter flask at 25 0 C. Anesthetic concentration of the
gas mixture was periodically assayed by gas chromatography using an
H-P model 7620 gas chromatograph equipped with flame ionization detectors.
The anesthetic was resolved with 3% OV-17 on Chromsorb W(HP) 80/100
mesh in a 1/8" x 8' stainless steel column at 100 0 C. A standard curve
was prepared by sampling the headspace of a sealed container of the
anesthetic maintained at a constant temperature.
Aliquots of an ETPp suspension were added to 1 ml volumes of the
anesthetic-equilibrated assay medium in a 1.2 ml quartz cuvette and the
reaction initiated within 1 minute by the addition of the appropriate substrate.
The change in absorbance at 340 nm was followed at 25 0 C with a Beckman
DB-G spectrophotometer. Anesthetics used were halothane (Ayerst),
methoxyflurane (Pittman-Moore), and diethyl ether (Mallinckrodt).
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The diethyl ether was extracted with 57/ aqueous ferrous sulfate and dried
over anhydrous sodium sulfate prior to use.
Assay of ETPp enzymatic activity at various pressures of argon
and nitrous oxide were conducted at 25 0 C as described for the luciferase
assay.
Re sults:
Both halothane and methoxyflurane were observed to be rather potent
inhibitors of NADH:O 2 oxidoreductase. The ED 5 0 (effective dose required
to produce a 50% inhibition of activity) concentrations for halothane and
methoxyflurane were 1. 95 and 0.38%, respectively. On the other hand,
50% inhibition of foreward transport was not realized with concentrations
of diethyl ether up to 9.6% at which the inhibition was 26%. Complete
inhibition of foreward electron transport was not observed with either
halothane or methoxyflurane at concentrations of up to 4%. The susceptability
of reverse flow, i.e., succinate:NAD oxidoreductase was tested only
with methoxyflurane. The ED 5 0 was estimated to be less than 0.1%.
(Difficulty was encountered in accurately determining the concentration
of methoxyflurane below 0.3%). Data for these anesthetics is shown in
Figure 1.
The affect of argon at pressures up to 120 ATM was negligible.
Although some inhibition was observed (between 2 and 5%), it was not
reproducible and assays with helium up to 100 ATM produced about the
same results. (It should be stressed that the overall error for this
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particular assay is on the average + 4%. ) Assays conducted with N 2 0
on the other hand, were somewhat more encouraging. Foreward electron
transport was completely inhibited at 40 ATM N 2 0; the ED 5 0 for this
anesthetic is about 18 ATM (Figure 2).
The effect of argon on reverse electron transport was evaluated
at pressures up to 120 ATM. The action of this gas was rather bizarre.
At 50 and 75 ATM reverse transport appears to be activated slightly re-
turning to control activity above 75 ATM and inhibited approximately 12%
at 120 ATM (Table 1). This behavior currently appears to be reproducible.
However, pressure controls with helium have not been performed and con-
sequently it is not certain whether this is an effect of argon or pressure.
The effect of N 2 0 on reverse transport has not been tested.
As observed with foreward electron transport, the activation of
firefly luciferin by luciferase is significantly inhibited by N 2 0 (Figure 2);
the ED 5 0 is slightly higher than that for ETP p:23 ATM. Unlike foreward
electron transport, complete inhibition was not observed at 40 ATM.
Contrary to the response of the respiratory chain, luciferase is inhibited
by argon at pressures of 50 and 100 ATM (Figure 2). The effect of
helium on luciferase activity at these pressures is also presented in
this figure.
Discussion:
The results reported here for halothane and methoxyflurane differ
considerably from those reported for the same anesthetics in the October
21
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Figure 2. Inhibition of ETP NADH Oxidase (upper most curve) by Nitrous Oxide and
the Inhibition of irefly Luciferase by Nitrous Oxide, Argon, and Helium
(lower curves).
Table I. Effect of Argon at Pressure on the Activity of
Succinate:NAD Oxidoreductase. Assays were per-
formed as described in text.
CONDITIONS n Velocity** o Inhibition
Control* 10 0.045 + 0.002 0
Argon, 50 ATM 5 0.048 + 0.001 -6.6
75 ATM 4 0.047 + 0.001 -4.4
Control 7 0.040 + 0.002 0
Argon, 120 ATM 4 0.035 + 0.002 +12.5
Control assays were run at ambient pressure in the absence of argon.
** Velocity = mean AA 3 4 0 /min + standard error.
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1973 Status Report. The latter data indicated ED 5 0 's of about 1.5 mM
and 2 mM for methoxyflurane and halothane, respectively, and contrast
with the 0.67 mM (0.35%) obtained for methoxyflurane and 1. 2 mM (1. 95%)
more recently determined. The current data are in better agreement with
the ED 5 0 's reported by Cohen and McIntyre (2) of 0.59% (methoxyflurane),
1. 35% (halothane) for the inhibition of glutamate oxidation by intact rat
liver mitochondria and calculated halothane ED 5 0 's of 1-2% for 3-hydroxy-
butyrate-mediated swelling of rat liver mitochondria (3). These may be
compared with the in vivo determined minimum alveolar concentrations
(MAC) for halothane of 0. 87% and for methoxyflurane of 0.23% (4),
although one should understand that the in vitro and in vivo endpoints may
not be identical because of the differences in the biological systems in-
volved.
The current data for the inhibition of NADH oxidase activity by
diethyl ether diverge considerably from the anticipated result. Cohen
and McIntyre observed an ED 5 0 for this anesthetic of 7.9% for the mi-
tochondrial oxidation of glutamate with nearly complete inhibition above
11%. The reported MAC for diethyl ether is 3% (4) and although Cohen's
value is more than 2-fold above this value, it is in better agreement with
the MAC than the ED 5 0 value of 18% extrapolated from our data. Harris,
et al (5), however, reported that a concentration of 340 mM ether, which
is equivalent to a 30% gas phase concentration, was required to effect 
a
94% inhibition of NADH oxidation by submitochondrial particles prepared
from bovine heart muscle. A linear extrapolation of our data to a 30%
25
gas phase concentration of ether would similarly predict a better than
90% inhibition of NADH oxidase activity. Even though such an extrapo-
lation is not entirely proper, because of the hyperbolic shape of the in-
hibition curve, it does indicate that our data are comparable to Harris'.
The discrepancies in these data may be attributed to several
reasons. Principal among these is that Cohen utilized intact mitochondria
oxidizing a NAD-linked substrate as opposed to the system used by Harris
and us in which the oxidation of NADH was followed directly. One could
argue that diethyl ether interferes inhibitorily with the movement of
glutamate into the mitochondria and its subsequent oxidation to oxoglutarate
as well as the oxidation of NADH. These are problems more exclusive to
intact mitochondria than submitochondrial particles. It is known that
both ether and methoxyflurane at moderate concentrations significantly
inhibit the oxidation of succinate by intact rat liver mitochondria, but
they do not affect the oxidation of this substrate by osmotic-shock prepared
submitochondrial particles (4). Higher concentrations of ether than those
used by Cohen, however, can inhibit the succinate oxidase activity of
submitochondrial particles (5). It is not clear whether there is any similarity
in the mechanism(s) of succinate oxidase inhibition in these two types of
preparations.
Another, but less likely possibility for the variance in the ether
data, is the manner in which the mitochondria and submitochondrial
particles were incubated with the anesthetic. Cohen pre-incubated rat
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liver mitochondria with ether (in the gas phase) at OOC. We, however,
pre-incubated the submitochondrial particles at 25 0 C with an assay medium
which had been equilibrated with this anesthetic at the same temperature.
Harris' procedure was essentially the same as ours, although the manner
in which the anesthetic was introduced to the assay medium differed
slightly. As a consequence of the much higher solubility of ether in
aqueous solutions at 0 0 C than at 25 0 C it is possible that its concentration
was significantly higher than estimated by the gas phase concentration.
The reason this seems to be an unlikely factor is apparent when our
data for halothane and methoxyflurane are compared with Cohen's. The
agreement is very good. Because of the differences in the assay systems,
the effect of pre-incubation temperature cannot be fully evaluated.
The effect of nitrous oxide on the rate of NADH oxidation by sub-
mitochondrial particles was rather startling in view of the anesthetic
potency of this gas (MAC 90%). The ED 5 0 for nitrous oxide calculated
from our data is about 18 ATM or 20-fold greater than the comparable
in vivo concentration. But this is close to the 14 ATM of nitrous oxide
required for 60% inhibition of either frog epithelial sodium transport or
sciatic nerve conduction (10). Nahrwold (11) found that a concentration
of nitrous oxide of 0.65 ATM did not inhibit the oxidation of NAD-linked
substrates by rat liver mitochondria. However, when combined with
various concentrations of halothane the effect of nitrous oxide was entirely
additive. No explanation was given for these results.
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Earlier Nahrwold and Cohen (12) empirically derived an equation
to predict the ED 5 0 values of various anesthetics based on their oil/gas
partition coefficients and concentrations required for 50% inhibition of
NAD-linked substrate oxidation:
log 1 0 ED 5 0 (%) = 2.746 - 1.035 log 1 0 O/G
where O/G is the oil/gas partition coefficient. This equation, which
predicts an ED 5 0 of 4 ATM for nitrous oxide, has been successfully used
to predict the synergistic effect of mixtures of nitrous oxide and halothane
in various ratios (11). The calculated N 2 0 ED 5 0 is obviously at some
variance with our data.
Similarly, when this equation is used to predict the ED 5 0 of
argon a value of 41.5 ATM is obtained. Since pressures of argon up to
3 times this value were without significant effect on NADH oxidation,
we feel this equation does not fully describe inhibition of NADH oxidation
by, presumably, active agents. A portion of the error could be attributed
to the differences in the biological assay materials: Nahrwold's equation
is based on assays with intact mitochondria, while our assays are performed
with sonically derived submitochondrial particles.
The greatest probable source of error is in the derivation of the
equation; it is based entirely on data for only six inhalation anesthetics.
In this light it is not likely to successfully predict the behavior of anesthe-
tics whose solubilities and molecular volumes deviate greatly from those
on which the equation is based.
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Using the ED 5 0 for nitrous oxide, however, we calculated the ED50
for argon to be approximately 150 ATM, which approximates the 163
ATM required to block frog sciatic nerve conduction (10). This calculation,
unlike Nahrwold's, takes into account the differences in aqueous and mem-
brane solubilities between these two gases as well as the difference in
their molecular volumes, all of which have significant bearing on
their relative effectiveness (13).
The difference between nitrous oxide and argon with respect to
membrane solubility is not as great as would be predicted by their dif-
ference in oil solubility, a factor of 1. 5 as opposed to 11, since the latter
fails to account for the presence of proteins and other non-lipid materials
commonly found in biological membranes. Furthermore, the oil solu-
bility coefficient does not account at all for their solubility in an aqueous
system, which is significant here because we are considering a three
phase system: gas, aqueous solution and a lipid/protein suspension, and
they differ by about a factor of 7. In addition to relative solubilities there
is a factor of 1.7 difference in their molecular volumes. The significance
of molecular volume in predicting relative anesthetic potencies was suggest-
ed by Mullins (14) and later extensively verified by Seeman (13). In
essence, Mullins' theory predicts that the efficiency of an anesthetic
is determined not only by its solubility, but on the volume it occupies as
well. Thus, assuming two compounds have the same solubilities, the one
with the larger molecular volume will, on the average, be the more effective.
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The data compiled by Seeman for the most part support the validity of
this theory.
Our data agree better with calculated membrane concentrations
not corrected for molecular volume than those in which this correction has
been made. Our very small sample of anesthetics, however, makes an
extrapolation to a general model somewhat difficult. This is evidenced by
the fact that we did not observe any inhibition of NADH oxidase at 120 ATM
of argon, a value which is close to the calculated ED 5 0 . We currently feel
that the high ED5 0 for N20 and the apparent lack of affect on NADH oxida-
tion by argon are attributable to factors not totally accounted for by
mathematical solutions encompassing various solubility factors and
molecular volumes.
One factor commonly not considered in such calculations is the
change in the chemical activity with pressure. From a series of
measurements on aqueous solutions of various gases among which
were argon, nitrogen and helium, Enns, et al (15) reported that on the
average the activity was increased by 14% at a pressure of 100 ATM.
This means that the apparent concentration of a gas in solution may be
14% higher than the true concentration. Concentration errors at lower
pressures are less. Thus, at a pressure of 120 ATM argon the effective
pressure would be slightly greater than 100 ATM.
To realize the calculated ED 5 0 for argon of 150 ATM, a pressure
of 200 ATM would be required. This is assuming that the ED 5 0 for
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nitrous oxide is in error by no more than 3% with regard to its true
concentration. The increase in activity may well explain the absence
of significant inhibition of NADH oxidase at high pressures of argon,
but it will not satisfactorily explain the high ED 5 0 for nitrous oxide; at
40 ATM the error would only be about 6%. In lieu of other explanations
the apparent anomalies are considered to be more biological than
physical in nature.
The complete cessation of succinate:NAD oxidoreductase activity oc-
curred at a gas phase concentration of methoxyflurane approximately
an order of magnitude below that required for comparable inhibition of
NADH oxidase. There are two explanations for this apparent low tolerance:
1) the reverse reaction being thermodynamically unfavorable, the
possible disorder effected by the presence of the anesthetic in complex
I may raise the energy requirement for the transport of electrons, and
2) the anesthetic may interfere with either the hydrolysis of ATP or the
coupling of the energy derived from this hydrolysis to complex I.
Harris (5) is of the opinion that a reduction of energy coupling to
complex I is not responsible for the inhibition, but rather is a reduction
of the enzymatic activity. Indeed, both Miller (3) and Rosenberg (6) ob-
served no change in either ADP/O or P/O ratios at concentrations of
halothane below 2-3%. Similarly, Cohen (2,7) reported that the uncoupling
of rat liver mitochondria occurred only above concentrations of 0.64% and
2% of methoxyflurane and halothane, respectively. However, halothane
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significantly inhibits energy-linked mitochondrial swelling with either
succinate or 3-hydroxybutyrate as a substrate (3) as well as the ATP-
or succinate-driven calcium uptake by rat brain mitochondria (6) at con-
centrations less than half of the ED 5 0 for foreward transport. Although
one might argue that the anesthetics, in the case of intact mitochondria, in-
terfere with substrate transport, the oxidation of succinate is not hindered
by concentrations of methoxyflurane or succinate well above their foreward
transport ED 5 0 's (3,7). Additionally, the ED 5 0 for reverse flow calcu-
lated from Harris' data yeilds a value which is similarly less than half
the foreward transport ED 5 0 . In accordance with these data the reverse
flow ED 5 0 determined for the current data indicates a value between one-
half and one-third of the foreward flow ED 5 0 . Finally, Snodgrass and Piras
(8) found that dinitrophenol-stimulated mitochondrial ATPase was inhibited
at halothane concentrations below those producing uncoupling. This is
in accordance with the observed reduction of mitochondrial ATP-P i
exchange in the presence of amytal (9).
Even though there are some significant problems involved in
making comparisons between different types of mitochondrial preparations,
it appears that the inhibition of reverse electron transport is more closely
related to inhibition of energy transduction than to the enzymatic activity of
complex I. A more rigorous study of the inhibition of this enzyme complex
by various clinical inhalation anesthetics will have to be conducted before
a more definitive conclusion can be drawn.
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Since we failed to detect significant inhibition of NADH oxidation
by argon, we turned to succinate:NAD oxidoreductase in the belief it
would be more sensitive to environmental perturbation than the foreward
reaction. Below 100 ATM reverse transport appears to be activated while
above it is inhibited. The degree of activation or inhibition, however,
is small, and the variation exceeds 2 standard errors of the mean.
Consequently, these changes are statistically nonsignificant.
If the apparent activation is real rather than artifactual it
would be interesting to determine its relationship to conformational
changes believed to occur in submitochondrial particles on energization
(15, 16). The activation phenomenon is most likely due to pressure
while inhibition is probably attributable to argon. However, these ef-
fects will have to be characterized more extensively with N 2 0, helium
and krypton.
The effect of nitrous oxide and argon at pressure on the activity
of firefly luciferase, was investigated, because this enzyme represents
a very simple system relative to the respiratory chain and is sensitive
to environmental perturbation, e.g. temperature, pressure, and hydro-
phobic agents. It also represents a non membrane system on which to
test the effect of inert gases. Ueda (17) has shown that luciferase activity
is reduced in the presence of several clinical inhalation anesthetics in a
manner which correlates with their solubility. He equated his results
to the theory of absolute reaction rates developed by Eyring and applied
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to bacterial luminescence by Eyring and Magee (18).
As applied to luciferase the theory, in essence, dictates that
inhibition occurs either by direct interaction of the inhibitor with the
active site(s) of the enzyme or by accelerating the conversion of the
enzyme from the active to inactive state (involving a conformation change).
The former is designated a type I inhibitor while the latter is type II.
In regard to the latter, Brown, et al (19) observed an increase in the
apparent volume of bacterial luciferase on conversion from the active
to inactive form. Johnson, et al (20) reported that the inhibitory effect
of hydrophobic compounds such as alcohol and urethane could be reversed
by hydrostatic pressures of several hundred ATM. From these data
Eyring and Magee concluded that certain hydrophobic agents accelerate
the formation of the inactive form of the luciferase by filling a
hydrophobic space in the enzyme and thereby preventing its conversion to
the active form.
Ueda's data demonstrates that the inhibition of luciferase occurs
as a type II process. He reported large negative changes in enthalpy and
entropy which approximately correlate with the oil solubility coefficients
of the anesthetics. He interpretates this behavior indicative of a con-
formational change or unfolding of the enzyme.
Both nitrous oxide and argon were observed to inhibit firefly
luciferase in a manner significantly correlated with their concentrations
corrected for solubility (r=0. 969, P<0. 01). These data are not
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sufficient to determine whether a type I or type II inhibition is involved,
since data at several temperatures is required. However, in view of the
correlation between inhibition and solubility it is currently assumed that
these data would fit the type II model.
The inhibition curve for helium is quite puzzling. It was believed
that these data represented an inhibition of luciferase by pressure, however,
Brown et al (19) indicate that pressure effects, within the range of
pressures used here and at the optimum temperature for the enzyme,
are negligible. In fact, one would expect luciferase activity to increase
with pressure rather than decrease, because the rate of conversion to
the inactive state would be reduced. Consequently, more of the enzyme
would be in the active form. Inhibition is less likely to be attributable
to helium, because of its very low solubility, more than an order of
magnitude below argon. Until this effect is further characterized, we
currently ascribe it to a contamination of helium with some active com-
pound, e.g. nitrogen.
In summary, we have found that both methoxyflurane and halothane
inhibit NADH oxidation by submitochondrial particles to about the same
degree as the inhibition of oxidation of NAD-linked substrates by intact
mitochondria. The inhibition of NADH oxidase by diethyl ether is con-
siderably less in submitochondrial particles than would be predicted by the
behavior of mitochondria. This may be due to either structural or sub-
strate differences, although the differences in methodology may also be
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significant.
The inhibition of ETP NADH oxidase by nitrous oxide occurred at
pressures 5-fold greater than that predicted from its effect on intact mito-
chondria. On the other hand, argon at pressures in considerable excess
of the predicted ED 5 0 were without effect on NADH oxidase. These dis-
crepencies are believed to be caused by the inadequacies of the prediction
model.
Methoxyflurane inhibited reverse electron flow at much lower levels
than required for comparable inhibition of foreward flow. A reduction of
complex I enzymatic activity or energy transduction would explain this
phenomenon. Argon may inhibit reverse flow at pressures above 120
ATM, but below this pressure it appears to activate this reaction.
Firefly luciferase was inhibited by both argon and nitrous oxide.
The inhibition of luciferase by N 2 0 was quite similar to its inhibition of
NADH oxidase. The activity of luciferase was also depressed by argon
up to pressures of 100 ATM, and demonstrates that membrane structures
are not a prerequisite for the action of an inert gas. The difference in the
amount of inhibition caused by these gases is proportional to their lipid
solubilities.
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APPENDIX
The following paper entitled, "A Rapid Quantitative Measure for
Comparative Metabolic Activity", by J.P. Jordan, C.L. Schatte, D.P.
Clarkson, M.L. Corrin, W.W. Martz and C.L. Clow has been prepared
for submission to the editors of Comparative Biochemistry and Physiology.
It is an expanded and up-dated version of work presented in an earlier
Status Report.
A RAPID QUANTITATIVE MEASURE FOR COMPARING METABOLIC
ACTIVITY
by
John Patrick Jordan, C. L. Schatte, D. P. Clarkson, M. L. Corrin,
W.W. Martz and D.J. Clow
Departments of Biochemistry and Mathematics
Colorado State University
Fort Collins, Colorado 80523
A RAPID QUANTITATIVE MEASURE FOR COMPARING METABOLIC
ACTIVITY
Abstract
A quick, simple measure of metabolic activity by measuring the
conversion of a 14C-labeled substrate (C ) to 1 4 CO 2 (P) is described.
A plot of In (C o - P) versus time provides a readily quantified parameter
sensitive to both changes in metabolic rate and the nature of the substrate
oxidized. Although acetate-1- 14 C was the substrate most frequently
used, labeled glucose and pyruvate have also been employed. The procedure
involves only an initial injection of labeled substrate followed by collection
of expired 1 4 CO 2 for approximately 60 minutes. The animal is not
anesthetized, restrained, or starved. The technique correlates well
with the standard but more difficult measurement of oxygen consumption.
metabolic rate; radioisotope kinetics; expired 14 CO 2
Introduction
Because of the definitive nature of mathematics, biologists have
long sought to use it as a tool for quantifying changes in animal metabolism.
While classical metabolic parameters such as oxygen consumption and
carbon dioxide production are used as whole body metabolic rate indica-
tors, it is advantageous to measure substrate level metabolic activity in
order to increase the sensitivity of measurements of metabolic aberra-
tions in the whole animal. Such a parameter must be quickly and easily
measured, readily quantified for comparative purposes, and cause mini-
mum disturbance to the animal. The development of such a parameter
has been crucial to work in this laboratory which is concerned with long-
term biochemical adaptation of rats to artificial environments. The need
to maintain as unperturbed a state as is possible while performing re-
peated measurements over periods of several weeks has prompted us
to search for a cellular level indicator that can be repeatedly and reproduci-
bly used while leaving the rats physiologically unaffected.
We have found that the injection of acetate-l- 1 4 C and treatment
of the resulting 14CO 2 expiration curve as a simple exponential function
provides us with an accurate measure of tricarboxylic acid (TCA) cycle
activity (and, therefore, a major part of cellular oxidative activity) which
is readily quantified for comparisons between different groups of animals.
The sampling time can be as little as 60 minutes, radioactive analysis
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requires no chemical treatment, and reproducibility can be as good
as 5%. Except for an initial intraperitoneal injection, the animals are
unrestrained, unstarved, uncatheterized, and essentially undisturbed in
the environment to which they are exposed.
The measurement of oxygen consumption, carbon dioxide production
and heat output have long been the standard means of assessing metabolic rate
of organisms. The use of various carbon-14-labeled compounds can
provide additional information concerning metabolism at the cellular
level. However, the usefulness of this information depends on the pre-
cise quantification of expired 14CO 2 data such that changes in metabolic
rate at the cellular level can be measured with good sensitivity.
We have applied a mathematical treatment to expired 14CO 2 data
in order to determine whether or not the sensitivity of such data could
be increased above that attendant upon standard integration of expired
14CO2 curves. When interpreted in conjunction with other metabolic
parameters, the procedure provides an additional measure of metabolic
rate plus insight into possible biochemical changes which may occur
even in the absence of a change in metabolic rate.
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Methods
In a series of twenty-five experiments, groups of rats were
exposed to artificial environments in a chamber system which has been
previously described (1,2) for periods of three days to thirteen weeks.
At intervals of one to seven days throughout the exposure, groups of
4-12 rats were injected intraperitoneally with 25-150 pCi/kg of sodium
acetate-l-14C in 0.3 - 0.5 ml distilled water. The expired gas was
bubbled through a carbon dioxide scrubber containing 10 liters of 3N
KOH. The contents of the scrubber was sampled for periods of 1-24
hours at intervals of 10 minutes for the first hour post-injection, 20 minutes
during the second hour, and 20, 30 or 60-minute intervals thereafter.
Activity of the samples was determined by pipetting 0.1 ml of the KOH
solution into 15 ml of p-dioxane - PPO - POPOP - naphthalene - ethanol -
Cab-O-Sil* and counting in a liquid scintillation spectrometer for three
5-minute counts each. A typical plot of the accumulative disintegrations
per minute versus time is shown in Figure 1. The shape of the curve and
its mathematical analysis have been rigorously treated by others (6,7,8)
as conforming to the general equation:
klt k2t k3t
A = Ale + A2e + A3e (1)
where A = activity in the expired CO 2 at a given time t
An = constant coefficient-intercepts of the individual peeled
components (n= 1, 2,3)
kn = constant values which represent the slope of the individual
peeled components (n=1,2,3)
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In equation 1 generally Ale , A 2 e and A 3 e are referred to respec-
tively as the fast, intermediate and slow components which make up the
equation.
We have found that it is only necessary to analyze the fast component
in order to get a quantitative measure of the metabolic activity of the
rat. An additional fact which supports the above is that we have found that
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factors likely to influence the shape and time course of the expired CO 2
curve do not vary appreciably in our experiments (i.e. bicarbonate pool
size, cellular uptake of C0 2 , exchange with bone). A satisfactory interpre-
tation has resulted by expressing the data as:
ln(14C injected/kg - 14C expired/kg) = InC o = kt
where k is the rate of decrease in total body activity per kilogram of rat,
t is time and C o is the total activity in the pool at time zero. There is a
ten minute dead time for our system. The dead time consists of the events
between injection of the substrate and its appearance as CO 2 in the scrubbers.
These include absorption into the blood, distribution to the cells, metabolic
conversion, transport to the lungs and expiration as C0 2 , equilibrium with
the chamber gas, and transport to and equilibrium with the scrubber con-
tents.
We have consistently obtained a good bit of the data for the fast
component which covers -a period of about 90 minutes. Thus, a sufficient
sampling period was available over the time interval 10-90 minutes in
order to calculate the slope and intercept of the intermediate curve.
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Additionally, both our data and the data of others (3,6) have indicated that
a substantial fraction of injected acetate is expired during a period of
one or, at most, two hours post injection. Subsequent elimination of
label from the body does not appear to significantly affect the results.
The slope of the logarithmic plot was determined by best fit of
a least squares regression analysis (Figure 2). The resulting value, k
or rate constant, was used for quantitative comparisons among different
experimentally-treated groups of animals.
To determine the relationship of this technique to the standard
dpm expired kg-1
measurements of oxygen consumption or the ratio dpm injected
ten adult, male hamsters were exposed to various treatments in the
chamber system. Exposure periods were for 72 hours during which
oxygen consumption was continuously measured over six-hour periods.
All exposures were in air at ambient pressure (5000 ft., 632 mm
Hg) at 22 0 C unless otherwise indicated. At the end of the exposure period,
the animals were injected with sodium acetate-l- C and the expired
CO 2 trapped in 3N KOH scrubbers. The scrubbers were sampled at
5 minute intervals during the first hour and every 10 minutes during the
second hour post injection. One-tenth ml of each sample was pipetted into
20 ml of p-dioxane- PPO- POPOP-naphthalene -ethanol-Cab-O-Sil cocktail
and counted in a liquid scintillation spectrophotometer for three 10-minute
counts each.
The effects of the number of animals injected (2,5 or 10), the dosage
(25, 50 or 100 uCi/kg made up to 25, 50 or 100 pCi/ml distilled water)
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and various treatments designed to alter metabolic rate were examined.
The treatments included exposure to argon-oxygen (4:1), nitrous oxide-
oxygen (4:1), barotrauma immediately prior to injection (decompression
from 5000 ft. to 20,000 ft. to 0 ft. to 5000 ft. at 1000 ft/min.), cold
exposure (12 0 C ambient and contamination of the chamber with argon
immediately prior to injection.
dpm expired kg-1
The activity data were corrected to dpm injected and the
logarithm plotted as a function of time. The resulting exponential curve
can be described by the equation (9):
A(t) = A(o)ekt
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where: A(t) = activity of CO 2 at time t
A(o) activity of 14CO 2 at t = 0
k = rate constant equal to the slope of the curve
The slope k, which was determined by linear regression, was
taken as a qualitative assessment of the rate of 1 4 C02 expiration and,
indirectly, as a measure of CO 2 production at the cellular level. These
values were correlated with the oxygen consumption during the final six
hours prior to injection and compared to the correlations between oxygen
consumption and integration of the expired 14CO 2 curve which was obtained
by summing the total dpm expired during the collection period.
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Re sults
As shown in Figure 3, the value of k will vary in magnitude as a
function of the catabolic rate of the injected substance; the greater the
rate, the greater the value of k. This particular set of curves represents
the conversion of acetate-1- 1 4 C to 14CO2 in rats exposed to neon-oxygen
for 4 weeks as compared with air controls and was calculated from
data previously published (4). In this case, acetate oxidation to CO 2
mirrored both total metabolic rate and the activity of the tricarboxylic
acid cycle; on that basis, the results graphically illustrate metabolic
adaptation to the neon environment for the four-week period.
The half-life of the metabolic pool can be determined by:
In 2
t 1/2= k
If the injected substrate mixes with the appropriate substrate
pool(s) of the body within about 10 minutes post injection, turnover rate
of the substrate's metabolic pool can be calculated in the absence of
significant changes in pool size during the mixing and measuring period.
Of further importance is the fact that the percentage of injected
substrate converted to CO 2 can be predicted with good accuracy from
the rate constant, k. Figure 4 shows the regression line of slope versus
percentage of injected label expired for periods of 2-3 hours post injection.
14
The points represent determinations with acetate-l- C injected into
rats whose age and weight varied from 90-240 days and 200-500 grams,
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respectively. The correlation coefficient of 0. 958 indicates that the
slope, determined during the first hour post injection, can serve to
predict the conversion of labeled acetate for up to three hours. It is
likely that little loss of accuracy would occur for longer collection periods
since a substantial amount of the injected compound is expired during the
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first hour after injection. With acetate-1- C, we have consistently
recovered 40-50% and as much as 75% of the injected label during the
first 60 minutes after injection. These values agree with the data of
Gould, et al (3) who recovered 50% of acetate-l- 1 4 C from rats in 42
minute s.
We have found the slope values to be repeatable within + 5% when at
least 4 animals are used. With groups of 6-12 animals, the sensitivity
is such that changes in catabolic rate due to time of day, prandial state,
and reaction to stress of handling are readily apparent. It is, however,
necessary to maintain a minimum level of total activity injected into the
animals. A group of 3 or 4 animals require 100-150 tCi/kg of body
weight to insure sufficient expired activity. Groups of 6-8 rats were
customarily injected with 50 pCi/kg while a 12-rat group needed only
25 pCi/kg for sufficient activity in the expired CO 2 . In the hamster
experiments, it can be seen (Table I.) that neither the number of animals
injected (2,5 or 10) or the dose (25, 50 or 100 p Ci/kg) had any substantial
effect on either the slope constant or the total activity expired.
The statistical analyses in Table 2 indicate that there were
significant correlations and regressions for both the slope constant k
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Table I. Results of Various Treatment Combinations Involving Number of
Animals Injected and Dose (pCi/kg) for VO2 (L/six hr kg-l),
Slope Constant k and Activity Expired as a Function of Activity
Injected.
No. Animals dpm expired
Treatment Injected Dose VO k(x 103) dpm injected
Air 10 50 9.50 6.32 .460
Air 10 50 9.74 7.08 .563
Air 10 50 10.19 9.19 .581
Air 10 25 9.39 6.60 .471
Air 10 100 10.92 9.33 .604
Air 5 100 8.74 8.00 .550
Air 2 100 10.73 8.39 .579
Ar/O 2  10 50 9.81 7.12 .482
N2 0/O 2  10 50 11.69 5.72 .488
Air (12 0 C) 10 50 14.60 11.65 .637
Air (barotrauma) 10 50 8.70 5.15 .439
Air (contaminate
w/Ar) 10 50 10.00 7.65 .480
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Table II. Statistical Results of Comparison of k Values Versus dpm expired
dpm injected
as an Indicator of Oxygen Consumption. (n = 12)
b s.d. t p r p
k .786 1.419 2.94 .025 .690 .01
dpm expired .0252 .0532 2.52 .050 .619 .05
dpm injected
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and total expired activity as a function of oxygen consumption. However,
the lower probability levels of the k data for both correlation and regres-
sion analyses suggest that the mathematical treatment offers a more
precise and reliable estimate of oxygen consumption, and therefore meta-
bolic rate, than does accumulative expired activity.
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Discussion
Requisite with the use of this analysis as an indicator of metabolic
rate are three assumptions. First, changes in the pool size must be
known or assumed to not occur under the experimental conditions.
Without plasma acetate specific activity measurements, the size of the
pool diluted by the tracer cannot be known; if pool size does change, then
an alteration in metabolic rate might be suggested when none, in fact,
occurred.
Second, changes in the fraction of the total acetate pool entering
the TCA cycle must be known or assumed to not occur. If changes in the
amount of label entering the TCA cycle do occur, an alteration in
metabolic rate would be implied when none had occurred. Such a
situation is readily detected by measuring CO 2 specific activity. Since
lipid biosynthesis is the only major alternative for acetate utilization,
changes in the rate of lipid synthesis can be measured by incorporation
studies. In the present circumstances, we have not found appreciable
changes in the fraction of total acetate entering the TCA cycle and have,
thus, been able to dispense with expired CO 2 specific activity measurements.
Third, it must be assumed that the appearance of 1 4 C0 2 in the
expired gas is proportional to its actual rate of oxidation; the experimental
conditions should not differentially alter those factors influencing the
correlation between actual oxidation rate and appearance as CO 2 in
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the expired gas. These factors include CO 2 diffusion constants, blood
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supply to the tissues, exchange of CO 2 with total body CO 2 "stores",
and ventilation rates. Gould, et al (3) pointed out that the rate of
catabolism and expiration of 14CO 2 can vary with the substrate. They
found the two rates did not differ in the case of acetate or bicarbonate
but that succinate osication was faster than its appearance as CO 2 in the
expired gas.
A further consideration, although untested as yet, is that the
pathway by which exogenous acetate enters the cell may be influenced
by the experimental conditions while endogenous acetate is not. The
latter enters an acetate pool primarily as a result of either carbohydrate
or fatty acid catabolism, whereas injected acetate must cross the cell
membrane, It is possible that the two routes of entry might be differen-
tially affected by an experimental condition such that the injected substrate
would not reflect the true endogenous situation. We feel that under our
experimental conditions of mild physiological stress, neither the number
of acetate pools which may exist nor the route of entry into the mitochoridria
complicate interpretation of the results.
The use of acetate as the test substrate minimizes these problems
while offering an optimal indicator for aerobic oxidation. Since the TCA
cycle is dependent on acetate as a substrate its activity must be sensitively
reflected in acetate pool flux. An additional advantage is that acetate up-
take by the cycle must be proportional to oxygen uptake by the cell and
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CO 2 produced from it since the major amount of oxygen consumption and
CO 2 production occurs via the TCA cycle. In our hands, the labeled
substrate method is significantly more sensitive than the measurement
of oxygen consumption or total CO 2 production.
Unlike many other metabolic substrates, acetate is used principally
for fatty acid synthesis, steroid synthesis and TCA cycle oxidation. With
inputs into the acetate pool mainly from pyruvate and fatty acid oxidation,
and outflow into the TCA cycle and lipid synthesis pathways, the variables
affecting pool size and turnover rate are limited. It is unlikely that minor
pathways such as ketone metabolism significantly influence acetate pool
characteristics in all but exceptional circumstances or specific tissues.
Thus, if in a given experiment there is some doubt about the validity of
the assumption that the fraction of the total acetate pool entering the TCA
cycle has not occurred, excellent challenge data can be obtained by simply
measuring the uptake of the acetate label into the total body lipid as a
function of time.
We have used labeled glucose in a similar manner with good results.
Since its pool fluctuates more drastically, correlation of its rate constant
with metabolic rate indicated by other parameters has not been quite as
good as with acetate. Using glucose-l- 1 4 C and glucose-6- 1 4 C and a
modification of the mathematical procedure of Katz, Landau and Bartsch
(5), we have been able to quantify both the aerobic and anaerobic catabolism
of glucose in rats (2). Rats in a marginally hyperoxic environment were
15
found to have "normal" total CO 2 production despite partial inhibition
of the pyruvate and succinate dehydrogenase systems, which caused
disruption of the TCA cycle as indicated by gas-solid chromatography
of TCA cycle intermediates. It was found that in the hyperoxic animals,
twice as much glucose was catabolized via the pentose phosphate pathway
at the expense of the glycolytic pathway. This accounted for the normal
total CO 2 production despite a slowing of the TCA cycle.
In this same series of experiments, analysis of 14CO 2 expiration
14
from injected pyruvate-2- C demonstrated conclusively that pyruvate
conversion to acetyl-CoA was altered in the hyperoxic state. It should be
emphasized that the method allows the animals to remain in as normal
a state as is possible under the conditions. This is particularly important
when subtle metabolic changes are being examined since starvation,
restraint, repeated withdrawal of blood, or removal to a foreign testing
apparatus often changes either the rate or the nature of metabolism so
as to obscure the effects of the test variable. Apart from the initial
injection, our rats were tested in the same environment and physiological
state to which they had become accustomed; the fact that the slope
constants predictably varied with the often marginal stressors to which
the animals were exposed is consistent with the concept that the results
are uncomplicated appreciably by other factors.
Of great importance, too, is the fact that the analytical procedure
is quick and simple. We have adapted a computer key punch to a liquid
16
scintillation counter which allows the counts to be prepared directly for
computer processing on the same day as the samples are counted.
17
Footnote
*PPO =2,5-Diphenyloxazole, New England Nuclear Corporation
POPOP =1,4 bis (2 (4-methyl-5-phenyloxazolyl) )-Benzene,
New England Nuclear Corporation
Cab-O-Sil-thixotropic gel, Cabot Corporation
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Figure 1. Graph of accumiulative disintegrations per minute
versus time in expired CO2 from 12 rats injected
14
with sodium acetate-l- 14C.
Figure 2. Graph of the logarithm of activity remaining in
the body versus time and a least squares regression
analysis of the data.
Figure 3. Graph showing regression analyses of data obtained
from rats exposed to either Ne-0 2 or air for four
weeks.
Figure 4. Graph of rat-e constant "k" versus the percentage
of injected label expired as 14CO 2 at three hours
past injection. The data were taken from 25 ex-
periments in which acetate-l-14C or glucose-UL-
14C were injected.
19
Fy Qire 3
25 ii
00
, 19.3O
1 3-. -C
0 1
20 40 60 8 100 20 40 60 80 100
miinutes post injec!io minUtes post injection
'" 
20
k 6 m 4
I
rii ils pt j it J mitcs post ijn ctio63
10 
r
o s: , i 1- -
C) 
'T
.= i
7f
_ 5
16.0 3t
2
20 40 60 80 100 10 20) 30 4U 50 60 70 80 90 100
rninutes pos) inujelin % expired
20
